Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Draft Biocides Directive could pose threat to in vitro diagnostics (IVD)

This article was originally published in Clinica

Executive Summary

The issue of whether IVDs should be excluded from the forthcoming Biocides Directive is being discussed by DG III and DG XI of the European Commission. This is a result of pressure from EUROM II, the European Federation of Precision, Mechanical and Optical Industries, and from the UK Association of the Laboratory Supply Industry (BLWA) on the UK's Health and Safety Executive and Medical Devices Agency.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts